Torrent Pharma launches Adalimumab in India under the brand “Adfrar”
Torrent Pharmaceuticals has launched bio similar Adalimumab, used for the treatment of auto immune disorders in India its under the brand name ‘Adfrar’. The company’s […]
Pharmaceuticals
Aurobindo Pharma receives approval for Norethindrone Acetate t
Aurobindo Pharma Ltd has received approval from the USFDA to manufacture and market Norethindrone Acetate tablets in USA. The approved Abbreviated New Drug Application (ANDA) […]
Aurobindo Pharma to set up manufacturing facility in Saudi Arabia
Aurobindo Pharma is planning to set up a pharma plant in Phase one of the King Abdullah Economic City’s (KAEC) Industrial Valley in Saudi Arabia. […]
Reliance Life Science receives USFDA approval for its Navi Mumbai facility
Reliance Life Sciences has received approval from the USFDA for its active pharmaceutical ingredient (API) manufacturing facility located at Dhirubhai Ambani Life Sciences Centre in […]
Zydus Cadilat to launch breast cancer drug Vivitra
Zydus Cadila has introduced a breast cancer drug in India, a copy of Swiss giant Roche’s product Herceptin. The company selling a version of trastuzumab […]
Glenmark to initiate novel drug for cancer
Glenmark Pharmaceuticals SA (GPSA), a wholly owned subsidiary of Glenmark Pharmaceuticals India, has announced the discovery and initiation of investigational new drug enabling studies for […]
Mylan Pharma launches Harvoni tablet for Hepatisis C
Mylan Pharma has launched generic Harvoni tablets, used to treat Hepatitis C, under the brand name ‘MyHep LVIR’ in India. The drug is an important […]
Indian government plans pharma technology upgradation fund for Rs. 5000 million
India is planning to set up a Rs 500-crore pharma technology upgradation fund which will facilitate cheaper loans to entities looking to upgrade their manufacturing […]
Cipla launches anti-hepatisis drug Ledipasvir
Cipla Ltd has launched the generic version of anti-hepatitis drug Ledipasvir-Sofosbuvir in the domestic market. The drug is used for treating hepatitis C virus. About […]
SMS Pharmaceuticals recieves USFDA approval for its Kandivalasa plant
SMS Pharmaceuticals has received approval from the USFDA for manufacturing facility in Kandivalasa in Visakhapatnam district of Andhra Pradesh. The USFDA had conducted inspection of […]